Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis.

Zhang Y, Lu H, Ji H, Lu L, Liu P, Hong R, Li Y.

Medicine (Baltimore). 2017 Dec;96(50):e9246. doi: 10.1097/MD.0000000000009246.

2.

Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.

Zhang Y, Zeng X, Liu P, Hong R, Lu H, Ji H, Lu L, Li Y.

Oncotarget. 2017 Jan 10;8(2):3454-3470. doi: 10.18632/oncotarget.13839.

3.

Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: A HuGE review and meta-analysis.

Yang YB, Zhao ZX, Huang W, Liu H, Tan YL, Wang WM.

J Cancer Res Ther. 2016 Apr-Jun;12(2):543-9. doi: 10.4103/0973-1482.148715. Review.

4.

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.

Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q.

Breast Cancer Res Treat. 2012 Dec;136(3):885-97. doi: 10.1007/s10549-012-2300-5. Epub 2012 Nov 4. Review.

PMID:
23124475
5.

Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects.

Zhang Y, Zeng X, Lu H, Ji H, Zhao E, Li Y.

Oncotarget. 2016 Oct 18;7(42):68002-68011. doi: 10.18632/oncotarget.12009.

6.

Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis.

Cui F, Wu D, Wang W, He X, Wang M.

Breast Cancer Res Treat. 2016 Jan;155(2):313-35. doi: 10.1007/s10549-015-3670-2. Epub 2016 Jan 4.

PMID:
26728143
7.

Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects.

Dai ZJ, Kang HF, Wang XJ, Shao YP, Lin S, Zhao Y, Ren HT, Min WL, Wang M, Liu XX.

Cancer Cell Int. 2014 Sep 5;14(1):91. doi: 10.1186/s12935-014-0091-y. eCollection 2014.

8.

Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.

Chan M, Ji SM, Liaw CS, Yap YS, Law HY, Yoon CS, Wong CY, Yong WS, Wong NS, Ng R, Ong KW, Madhukumar P, Oey CL, Tan PH, Li HH, Ang P, Ho GH, Lee AS.

Breast Cancer Res Treat. 2012 Nov;136(1):209-20. doi: 10.1007/s10549-012-2234-y. Epub 2012 Sep 11.

PMID:
22965832
9.

Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.

Jia C, Cai Y, Ma Y, Fu D.

Breast Cancer Res Treat. 2010 Nov;124(2):521-8. doi: 10.1007/s10549-010-0872-5. Epub 2010 Apr 4. Erratum in: Breast Cancer Res Treat. 2010 Nov;124(2):529. Jia, Chenyou [corrected to Jia, Chengyou].

PMID:
20364400
10.
11.

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.

Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.

Menopause. 2013 Mar;20(3):354-8. doi: 10.1097/GME.0b013e318268ca46.

12.

A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.

Li T, Zhao J, Yang J, Ma X, Dai Q, Huang H, Wang L, Liu P.

PLoS One. 2016 Apr 12;11(4):e0153314. doi: 10.1371/journal.pone.0153314. eCollection 2016. Erratum in: PLoS One. 2018 Jan 17;13(1):e0191579.

13.

Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.

Wang H, Yang Z, Zhang H.

Breast Cancer Res Treat. 2013 Jan;137(2):511-22. doi: 10.1007/s10549-012-2343-7. Epub 2012 Nov 27.

PMID:
23184080
14.

FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.

Barnholtz-Sloan JS, Shetty PB, Guan X, Nyante SJ, Luo J, Brennan DJ, Millikan RC.

Carcinogenesis. 2010 Aug;31(8):1417-23. doi: 10.1093/carcin/bgq128. Epub 2010 Jun 16.

15.

Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.

Peng S, Lü B, Ruan W, Zhu Y, Sheng H, Lai M.

Breast Cancer Res Treat. 2011 Jun;127(2):309-24. doi: 10.1007/s10549-011-1459-5. Epub 2011 Mar 29. Review.

PMID:
21445572
16.

Association between three functional microRNA polymorphisms (miR-499 rs3746444, miR-196a rs11614913 and miR-146a rs2910164) and breast cancer risk: a meta-analysis.

Zhang H, Zhang Y, Yan W, Wang W, Zhao X, Ma X, Gao X, Zhang S.

Oncotarget. 2017 Jan 3;8(1):393-407. doi: 10.18632/oncotarget.13426.

17.

Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.

Chen Q, Shi R, Liu W, Jiang D.

PLoS One. 2013 Aug 16;8(8):e72487. doi: 10.1371/journal.pone.0072487. eCollection 2013.

18.

Polymorphism of HSD17B1 Ser312Gly with Cancer Risk: Evidence from 66,147 Subjects.

Shi L, Yang X, Dong X, Zhang B.

Twin Res Hum Genet. 2016 Apr;19(2):136-45. doi: 10.1017/thg.2016.6. Epub 2016 Feb 29.

PMID:
26923943
19.

Effects of interleukin-10 polymorphisms (rs1800896, rs1800871, and rs1800872) on breast cancer risk: evidence from an updated meta-analysis.

Dai ZJ, Wang XJ, Zhao Y, Ma XB, Kang HF, Min WL, Lin S, Yang PT, Liu XX.

Genet Test Mol Biomarkers. 2014 Jun;18(6):439-45. doi: 10.1089/gtmb.2014.0012. Epub 2014 Apr 10.

PMID:
24720854
20.

Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.

Mazhar A, Jamil F, Bashir Q, Ahmad MS, Masood M, Tanvir I, Rashid N, Waheed A, Afzal MN, Tariq MA.

Mol Med Rep. 2016 Oct;14(4):3443-51. doi: 10.3892/mmr.2016.5633. Epub 2016 Aug 18.

PMID:
27572905

Supplemental Content

Support Center